1 In a press release, Mark Cuban Cost Plus Drug Company CEO Alex Oshmyansky said, We are thrilled to collaborate with 9amHealth in our mission to make prescription drugs more affordable for consumers
The most honest answer is: it depends on what you mean by "work" and what application you have in mind
Zepbound, approved in 2023, had similar persistence rates
Plaintiffs allege that AstraZeneca failed to adequately warn patients and prescribing physicians about the potential risks, despite growing concerns within the medical community and clinical trial data suggesting dangers
Most physicians instruct patients to inject at the same time every day, typically in the morning or at bedtime, depending on the treatment protocol
This move will likely increase the number of people taking Wegovy, which is nearly 1 million people